WEST DES MOINES, Iowa, Aug. 13, 2019 /PRNewswire/ -- CHC Health, announced today that former Humana/CVS Health executive, Andy Papa, has joined their C-suite management team as the Chief Revenue Officer.  Andy will lead business development, marketing and sales strategies across the spectrum of CHC Health's lines of business.  In

MANHASSET, N.Y., Aug. 13, 2019 /PRNewswire/ -- Feinstein Institutes for Medical Research scientists are the first to publish clinical trial results of an inv

Company continues to expand its portfolio of highly selective antibodies targeting root cause of Alzheimer's, ALS and Parkinson's disease TORONTO and CAMBRIDGE, MA, Aug. 13, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and developm

HOUSTON, Aug. 13, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its proof of concept clinical trial to evaluate its p-STAT3 inhibitor, WP1220, for the topical treatment of Cutaneous T-Cell

BETHESDA, Md., Aug. 13, 2019 /PRNewswire/ -- Healthy Directions LLC, a subsidiary of Adaptive Health, LLC, is proud to announce its corporate sponsorship of Vitamin Angels, a global public health nonprofit that distributes lifesaving vitamins and minerals to women and children in need around the world.

MONMOUTH JUNCTION, N.J., Aug. 13, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its

VANCOUVER, Aug. 13, 2019 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce that it has signed a purchase agreement (the "Agreement") to acquire Ninetails Cannabis Inc. ("Ninetails"), a licensed ca

CUPERTINO, Calif., Aug. 13, 2019 /PRNewswire/ -- Corinth MedTech, a medical device company and the developer of the Veloxion™ System for relieving the

PRINCETON, N.J., Aug. 13, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended

TARRYTOWN, N.Y., Aug. 13, 2019 /PRNewswire/ -- EYLEA is the only anti-VEGF approved to treat four retinal conditions with a single dose strength prefilled syringeEYLEA is available in multiple dosing intervals, offering doctors flexibility to address patients' individual needs